Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes

BACKGROUND: Ovarian carcinomas presenting homologous recombination deficiency (HRD), which is observed in about 50% of cases, are more sensitive to platinum and PARP inhibitor therapies. Although platinum resistant disease has a low chance to be responsive to platinum-based chemotherapy, a set of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Alexandre A. B. A., do Canto, Luisa M., Larsen, Simon Jonas, Ribeiro, Adriana Regina Gonçalves, Stecca, Carlos Eduardo, Petersen, Annabeth Høgh, Aagaard, Mads M., de Brot, Louise, Baumbach, Jan, Baiocchi, Glauco, Achatz, Maria Isabel, Rogatto, Silvia Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503431/
https://www.ncbi.nlm.nih.gov/pubmed/31060523
http://dx.doi.org/10.1186/s12885-019-5622-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503431/
https://www.ncbi.nlm.nih.gov/pubmed/31060523
http://dx.doi.org/10.1186/s12885-019-5622-4

Ejemplares similares